Annalyse Treat v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2024)

Filed 2022-07-08Decided 2024-08-08Vaccine Influenza
compensated$166,589

Case summary [AI summaries can sometimes make mistakes]

Annalyse Treat filed a petition on July 8, 2022, alleging that the influenza vaccine she received on September 19, 2019, caused her to develop Guillain-Barre Syndrome (GBS) and suffer residual effects for more than six months. The influenza vaccine is listed on the Vaccine Injury Table.

Respondent denied that the flu vaccine caused GBS or any other injury. Despite the denial, the parties filed a joint stipulation to resolve the case.

Special Master Christian J. Moran reviewed the stipulation, found it reasonable, and adopted it as the Court's decision.

Ms. Treat was awarded a lump sum of $166,589.92, payable by check to petitioner, as compensation for all damages available under 42 U.S.C. § 300aa-15(a).

This award was made on August 8, 2024, concluding the case. Petitioner was represented by Leigh Finfer of Muller Brazil, LLP, and Respondent was represented by Lynn Christina Schlie of the United States Department of Justice.

The public decision was issued on August 8, 2024.

Source PDFs 2 total · 2 downloaded